1. Denapaite, D., y Hakenbeck, R. (2011). A new variant of the capsule 3 cluster occurs in Streptococcus pneumoniae from deceased wild chimpanzees. PLoSOne. 6: e25119
2. Kadioglu A, Weiser JN, Paton JC,Andrew PW. (2008).The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008 Apr;6(4):288-301. doi: 10.1038/nrmicro1871. PMID: 18340341
3. UNICEF, y WHO (2006). Pneumonia: the forgotten killer of children.http://www.unicef.org/spanish/publications/files/Pneumonia_The_Forgotten_Killer_of_Children.pdf.
4. UNICEF (2015). UNICEF global databases 2015. https://data.unicef.org/
5. OMS (2016). Neumonía. http://www.who.int/mediacentre/factsheets/fs331/es/
6. Cooper G, Rosenstein C, Walter A, Peizer L. (1932). The further separation of types among the pneumococci hitherto included in group IV and the development of therapeutic antisera for these types. J Exp Med55:531–554. http://dx.doi.org/10.1084/jem.55.4.531.
7. Beckler E, Macleod P. (1934). The Neufeld method of pneumococcus type determination as carried out in a public health laboratory: a study of 760 typings. J Clin Invest 13:901–907. http://dx.doi.org/10.1172/JCI100634
8. Lund E. (1960). Laboratory diagnosis of pneumococcus infections. Bull World Health Organ 23:5–13.
9. Ganaie Feroze, Jamil S. Saad, Lesley McGee, Andries J. van Tonder, Stephen D. Bentley, Stephanie W. Lo, Rebecca A. Gladstone, Paul Turner, Jeremy D. Keenan, Robert F. Breiman, Moon H. Nahm. (2020). A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus. mBio May 2020, 11 (3) e00937-20; DOI: 10.1128/mBio.00937-20
10. Grabenstein JD, Klugman KP. (2012). A century of pneumococcal vaccination research in humans. Clin Microbiol Infect 18(Suppl 5):S15–S24. http://dx.doi.org/10.1111/j.1469-0691.2012.03943.x.
11. Oliveira GS, Oliveira MLS, Miyaji EN, Rodrigues TC. Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines (Basel). 2021 Nov 17;9(11):1338. doi: 10.3390/vaccines9111338. PMID: 34835269; PMCID: PMC8620834.Musher, D.M., Anderson, R. & Feldman, C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia 14, 5 (2022). https://doi.org/10.1186/s41479-022-00097-y
12. Lineamientos tecnicos Vacunacion contra Neumococo. DiCEI. Ministerio de Salud de la Nacion. Acceso. Available from: http://www.msal.gob.ar/images/ stories/bes/graficos/0000000947cnt-Lineamientos_neumo_adultos_WEB.pdf.
13. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014;14:13.
14. Flasche S et al. Effect of pneumococcal conjugate vaccination on serotypespecific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011;8:e1001017.
15. Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002;51:98-104.
16. Obolski Uri, LourencÃßo JoseÃÅ, Thompson Craig, Thompson Robin, Gori Andrea, Gupta Sunetra. Vaccination can drive an increase in frequencies of antibiotic resistance among non-vaccine serotypes of Streptococcus pneumoniae. Proc Natl Acad Sci 2018;115(12):3102-7. https://doi.org/10.1073/ pnas.1718712115.
17. Lehtinen S et al. Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage. Proc Natl Acad Sci USA 2017;114:1075-80.
18. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population based surveillance. Lancet Infect Dis 2015;15(3):301-9. https://doi.org/10.1016/S1473-3099(14)71081-3.
19. Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine 2015;33(Suppl 4): D60-5. https://doi.org/10.1016/j.vaccine.2015.05.102.
20. Kallow, W., Erhard, M., Shah, H.N., Raptakis, E. and Welker, M. (2010). MALDI-TOF MS for Microbial Identification: Years of Experimental Development to an Established Protocol. In Mass Spectrometry for Microbial Proteomics (eds H.N. Shah and S.E. Gharbia). https://doi.org/10.1002/9780470665497.ch12
21. He Y, Li H, Lu X, Stratton CW, Tang YW. Mass spectrometry biotyper system identifies enteric bacterial pathogens directly from colonies grown on selective stool culture media. J Clin Microbiol. 2010;48(11):3888-3892. doi:10.1128/JCM.01290-10
22. Cherkaoui A, Hibbs J, Emonet S, et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol. 2010;48(4):1169-1175. doi:10.1128/JCM.01881-09
23. Rocca MF, Zintgraff JC, Dattero ME, et al. A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs. J Virol Methods. 2020;286:113991. doi:10.1016/j.jviromet.2020.113991
24. Tran A, Alby K, Kerr A, Jones M, Gilligan PH. 2015. Cost savings realized by implementation of routine microbiological identification by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 53:2473–2479. doi: 10.1128/JCM.00833-15
25. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization–time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 49:1614–1616. doi: 10.1128/JCM.02381-10.
26. Wang, H.Y., Lien, F., Liu, T.P., Chen, C.H., Chen, C.J., Lu, J.J., (2018). Application of aMALDI-TOF analysis platform (ClinProTools) for rapid and preliminary report ofMRSA sequence types in Taiwan. PeerJ. 6, e5784. https://doi.org/10.7717/peerj.5784
27. MALDI Biotyper 3.1 User Manual.
28. Bruker Daltonik GmbH, 2011.ClinPro Tools User Manual Version 3.0.BrukerDaltonik GmbH, Bremen.
29. Camoez, M., Sierra, J.M., Dominguez, M.A., Ferrer-Navarro, M., Vila, J., Roca, I., 2016. Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry. Clin.Microbiol. Infect. 22 (2) https://doi.org/10.1016/j.cmi.2015.10.009, 161.e1-161. e7.
30. MALDIquantForeign: Import/Export Routines for MALDIquant. v. 0.12 (2019).
31. Gibb, S. & Strimmer, K. MALDIquant: A versatile R package for the analysis of mass spectrometry data. Bioinformatics 28, 2270–2271. https://doi.org/10.1093/bioinformatics/bts447 (2012).
32. factoextra: Extract and visualize the results of multivariate data analyses v. R package version 1.0.6 (2019).
33. Gibb, S. & Strimmer, K. binda: Multi-class discriminant analysis using binary predictors. R package version 1.0.3. (2015)
34. Landis, J. Richard, and Gary G. Koch. (2022) “The Measurement of Observer Agreement for Categorical Data.” Biometrics, vol. 33, no. 1, 1977, pp. 159–74, https://doi.org/10.2307/2529310. Accessed 6 May 2022.
35.
36. Zhang, H., Cao, J., Li, L., Liu, Y., Zhao, H., Li, N., Li, B., Zhang, A., Huang, H., Chen, S.,Dong, M., Yu, L., Zhang, J., Chen, L., (2015). Identification of urine protein biomarkers with the potential for early detection of lung cancer. Sci. Rep. 5, 11805. https://doi.org/10.1038/srep11805.
37. Stephens, M.A., 1974. EDF statistics for goodness of fit and some comparisons.JASA 69,730–737.
38. Lavigne JP, Espinal P, Dunyach-Remy C, Messad N, Pantel A, Sotto (2013) A. Mass spectrometry: a revolution in clinical microbiology?. Clin Chem Lab Med. 2013;51(2):257-270. doi:10.1515/cclm-2012-0291
39. Maria Florencia Rocca, Marisa Almuzara, Claudia Barberis, Carlos Vay, PilarVines y Mónica Prieto. (2019) Presentation of the National Network for Microbiological Identification by Mass Spectrometry website. Guide for the interpretation of MALDI-TOF MS results. https://doi.org/10.1016/j.ram.2019.03.001
40. Yumi Kubo, Osamu Ueda, Sawa Nagamitsu, Hachiro Yamanishi, Akihiro Nakamura, Masaru Komatsu, (2021) Novel strategy of rapid typing of Shiga toxin-producing Escherichia coli using MALDI Biotyper and ClinProTools analysis, Journal of Infection and Chemotherapy,Volume 27, Issue 8, 2021,https://doi.org/10.1016/j.jiac.2021.03.002.
41. Selali Fiamanya, Lucía Cipolla, Mónica Prieto, John Stelling, (2021) Exploring the value of MALDI-TOF MS for the detection of clonal outbreaks of Burkholderia contaminans, Journal of Microbiological Methods,Volume 181,2021,106130,ISSN 0167-7012, https://doi.org/10.1016/j.mimet.2020.106130.
42. Gubbi, S., Hamet, P., Tremblay, J., Koch, C. A., & Hannah-Shmouni, F. (2019). Artificial intelligence and machine learning in endocrinology and metabolism: the dawn of a new era. Frontiers in Endocrinology, 10, 185.
43. Göran Landberg, Emma Jonasson, Anna Gustafsson, Paul Fitzpatrick, Pauline Isakson, Joakim Karlsson, Erik Larsson, Andreas Svanström, Svanheidur Rafnsdottir, Emma Persson, Daniel Andersson, Jennifer Rosendahl, Sarunas Petronis, Parmida Ranji, Pernilla Gregersson, Ylva Magnusson, Joakim Håkansson, Anders Ståhlberg, (2020) Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data, Data in Brief,Volume 31,2020,105860, ISSN 2352-3409,
44. Lau AF. Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification. Clin Lab Med. 2021;41(2):267-283. doi:10.1016/j.cll.2021.03.006
45. Rupf, S., Breitung, K., Schellenberger, W., Merte, K., Kneist, S. and Eschrich, K. (2005), Differentiation of mutans streptococci by intact cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Oral Microbiology and Immunology, 20: 267-273. https://doi.org/10.1111/j.1399-302X.2005.00223.x
46. Friedrichs C., Rodloff A. C., Chhatwal G. S., Schellenberger W., Eschrich K. (2007). Rapid identification of Viridans Streptococci by mass spectrometric discrimination. J. Clin. Microbiol. 45 2392–2397. 10.1128/JCM.00556-07
47. La Scola B, Raoult D. (2009) Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One. 2009;4(11):e8041. Published 2009 Nov 25. doi:10.1371/journal.pone.0008041
48. Stevenson, L. G., Drake, S. K., & Murray, P. R. (2010). Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Journal of clinical microbiology, 48(2), 444-447.
49. Risch M., Radjenovic D., Han J. N., Wydler M., Nydegger U., Risch L. (2010). Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med. Wkly 140, w13095. 10.4414/smw.2010.13095
50. Welker M, Moore ERB. (2011) Applications of whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry in systematic microbiology. Syst Appl Microbiol 2011; 34: 2–11.
51. Werno AM, Christner M, Anderson TP, Murdoch DR. (2012). Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 50: 2863–2867.
52. Ikryannikova, L. N., Filimonova, A. V., Malakhova, M. V., Savinova, T., Filimonova, O., Ilina, E. N., ... & Govorun, V. M. (2013). Discrimination between Streptococcus pneumoniae and Streptococcus mitis based on sorting of their MALDI mass spectra. Clinical Microbiology and Infection, 19(11), 1066-1071.
53. Chen, J. H., She, K. K., Wong, O. Y., Teng, J. L., Yam, W. C., Lau, S. K., et al. (2015). Use of MALDI Biotyper plus ClinProTools mass spectra analysis for correct identification of Streptococcus pneumoniae and Streptococcus mitis/oralis. J. Clin. Pathol. 68, 652–656. doi: 10.1136/jclinpath-2014-202818
54. Marín, M., Cercenado, E., Sánchez-Carrillo, C., Ruiz, A., Gómez González, Á., Rodríguez-Sánchez, B., & Bouza, E. (2017). Accurate differentiation of Streptococcus pneumoniae from other species within the Streptococcus mitis group by peak analysis using MALDI-TOF MS. Frontiers in Microbiology, 8, 698.
55. Ercibengoa M, Alonso M, Vicente D, Morales M, Garcia E, Marimón JM. (2019) Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping. PLoS One. 2019 Feb 12;14(2):e0212022. doi: 10.1371/journal.pone.0212022. PMID: 30753210; PMCID: PMC6372175.
56. Nakano, S., Matsumura, Y., Ito, Y., Fujisawa, T., Chang, B., Suga, S., ... & Ichiyama, S. (2015). Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases, 34(11), 2191-2198.
57. Pinto T, Costa N, Castro L, Ribeiro R, Botelho A, Neves F et al. (2017) Potential of MALDI-TOF MS as an alternative approach for capsular typing Streptococcus pneumoniae isolates. ScientificReports. 2017;7(1)